Ftse Mib
36.059,17
-0,23%
DAX
21.042,00
0,18%
S&P 500
6.049,24
0,88%
NASDAQ
19.756,78
0,64%
Bitcoin
105.522,73
-0,61%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Achilles Therapeutics PLC (ACHL) Achilles Therapeutics PLC (ACHL) Notizie

Achilles Therapeutics PLC

ACHL
1,16
0,02 (1,75%)
22 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/1/202522:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/12/202415:30GLOBEAchilles Therapeutics Announces Sale of Technology Assets to..
02/12/202414:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/11/202413:00GLOBEAchilles Therapeutics Receives Approval to Transfer to..
14/11/202415:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202413:00GLOBEAchilles Therapeutics Reports Third Quarter 2024 Financial..
19/9/202413:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202413:00GLOBEAchilles Therapeutics Announces Strategic Update
14/8/202414:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202413:00GLOBEAchilles Therapeutics Reports Second Quarter 2024 Financial..
05/8/202422:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/5/202413:00GLOBEAchilles Therapeutics Announces Research Collaboration with..
17/5/202423:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/5/202423:00GLOBEAchilles Therapeutics Receives Nasdaq Deficiency Notice..
08/5/202413:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/5/202413:00GLOBEAchilles Therapeutics Reports First Quarter 2024 Financial..
04/4/202412:45GLOBEAchilles Therapeutics Reports Fourth Quarter and Year-End..
04/4/202412:30GLOBEAchilles Therapeutics Provides Interim Phase I/IIa Update on..
05/2/202413:00GLOBEAchilles Therapeutics to Present at the 10th Annual..
01/2/202419:14EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 1,13 Min: 1,1206 Max: 1,16
Chiusura: 1,14

La tua Cronologia

NASDAQ
ACHL
Achilles Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network